SAFC is investing $12m in its viral product manufacturing facility in Carlsbad, California. Due to be operational in H2 2009, the two fully segregated state-of-the-art manufacturing suites will add 800m2 of manufacturing space and utilise disposable technologies.
In-Pharma Technologist
Tuesday 15 January 2008
SAFC invests in biologics
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment